Protocol No.

165274 (IMCgp100-203)

Principal Investigator

Hu-Lieskovan, Siwen

Phase

II/III

Age Group

Adult

ClinicalTrials.Gov

NCT05549297 (Click to jump to clinicaltrials.gov)

Title

Phase II/III Randomized Study of Tebentafusp as Monotherapy and in Combination with Pembrolizumab Versus Investigator?s Choice in HLA-A*02:01-positive Participants with Previously Treated Advanced Melanoma (TEBE-AM)

Objective